Absence of SARS-CoV-2 in a captive white-tailed deer population in Alabama, USA

Figures & data

Table 1. Molecular and serological prevalence of SARS-CoV-2 in deer

Country, State	Sampling period	Sample; detection method	Prevalence; SARS-CoV-2 lineages identified	Reference
USA: OH	January–March, 2021	Nasal swabs; RT-PCR	35.8%; 129/360; B.1.2, B.1.596, B.1.582	[7]
USA: MI, PA, IL, NY	2011–2021	Serum; sVNT	40.0%; 152/624	[6]
USA: IA	April 2020–January 2021	Retropharyngeal lymph node; RT-PCR	33.2%; 94/283; B.1, B.1.1, B.1.119, B.1.2 51, B.1.234, B.1.240, B.1.264, B.1.311, B.1.362, B.1.400, B.1.459, B.1.596	[8]
USA: NY	December 2021–January 2022	Serum; sVNT	14.5%; 19/131	[10]
		Nasal swabs; RT-PCR	10.3%; 7/68 B.1.1.529
USA: TX	January–February 2021	Serum; plaque reduction neutralization assay	37.0%; 20/54	[11]
USA: TX	September–November 2021	Serum; plaque reduction neutralization assay	Facility A: 94.4%; 34/36; facility B: 0.0%; 0/16: facility C: 0.0%; 0/29	[9]
		Respiratory and rectal swabs; RT-PCR	0.0%; 0/80
USA: SC	N/A	Serum; Neutralizing antibody assay	9.0%; 2/22	[12]
Canada: QC	Nov 2021	Nasal swabs; RPLNs; RT-PCR	1.2%; 3/251 (nasal swab); 0.0%; 0/104 (RPLNs); B.1.617.2 (lineage AY.44)	[13]
		Thoracic cavity fluid; neutralizing antibody assay	5.6%; 14/251
UK	January 2020–May 2021	Serum; sVNT	0.0%; 0/1748	[14]
Germany	January 2020–December 2021	Serum; sVNT	0.0%; 0/181	[15]
Austria	January 2020–December 2021	Serum; sVNT	0.0%; 0/51	[15]

Hale VL, Dennis PM, McBride DS, et al. SARS-CoV-2 infection in free-ranging white-tailed deer. Nature. 2021.

 PubMed Web of Science ®Google Scholar

Chandler JC, Bevins SN, Ellis JW, et al. SARS-CoV-2 exposure in wild white-tailed deer (Odocoileus virginianus). Proc Natl Acad Sci U S A. 2021;118(47):e2114828118.

 PubMed Web of Science ®Google Scholar

Kuchipudi SV, Surendran-Nair M, Ruden RM, et al. Multiple spillovers from humans and onward transmission of SARS-CoV-2 in white-tailed deer. Proc Natl Acad Sci U S A. 2022;119(6):e2121644119.

 PubMed Web of Science ®Google Scholar

Vandegrift KJ, Yon M, Surendran-Nair M, et al. Detection of SARS-CoV-2 Omicron variant (B.1.1.529) infection of white-tailed deer. bioRxiv [Preprint]. 2022:2022.02.04.479189.

 Google Scholar

Palermo PM, Orbegozo J, Watts DM, et al. SARS-CoV-2 neutralizing antibodies in white-tailed deer from Texas. Vector Borne Zoonotic Dis. 2022;22(1):62–64.

 PubMed Web of Science ®Google Scholar

Roundy CM, Nunez CM, Thomas LF, et al. High seroprevalence of SARS-CoV-2 in white-tailed deer (Odocoileus virginianus) at one of three captive cervid facilities in Texas. Microbiol Spectr. 2022: e0057622.

 PubMed Web of Science ®Google Scholar

Hancock TJ, Hickman P, Kazerooni N, et al. Possible cross-reactivity of feline and white-tailed deer antibodies against the SARS-CoV-2 receptor binding domain. J Virol. 2022;96(8):e0025022.

 PubMed Web of Science ®Google Scholar

Kotwa JD, Massé A, Gagnier M, et al. First detection of SARS-CoV-2 infection in Canadian wildlife identified in free-ranging white-tailed deer (Odocoileus virginianus) from southern Québec, Canada.

 Google Scholar

Holding M, Otter AD, Dowall S, et al. Screening of wild deer populations for exposure to SARS-CoV-2 in the United Kingdom, 2020-2021. Transbound Emerg Dis. 2022.

 PubMed Web of Science ®Google Scholar

Moreira-Soto A, Walzer C, Czirják GÁ, et al. Serological evidence that SARS-CoV-2 has not emerged in deer in Germany or Austria during the COVID-19 pandemic. Microorganisms. 2022;10(4):748.

 PubMed Web of Science ®Google Scholar